Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 66611-37-8 Chemical Structure| 66611-37-8

Structure of BGP-15
CAS No.: 66611-37-8

Chemical Structure| 66611-37-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

Synonyms: BGP-15 2HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BGP-15

CAS No. :66611-37-8
Formula : C14H24Cl2N4O2
M.W : 351.27
SMILES Code : N=C(NOCC(O)CN1CCCCC1)C2=CN=CC=C2.[H]Cl.[H]Cl
Synonyms :
BGP-15 2HCl
MDL No. :MFCD21603901

Safety of BGP-15

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Related Pathways of BGP-15

epigenetics
DNA

Isoform Comparison

Biological Activity

Target
  • PARP

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse zygotes 10 µM 6 hours Reduced mitochondrial reactive oxygen species (mtROS) levels and improved mitochondrial function PMC11909127
Mouse MII oocytes 10 µM 8 hours Reduced mitochondrial reactive oxygen species (mtROS) levels and restored ICM telomere length PMC11909127
A549 cells 10µM 48 hours Pretreatment with BGP-15 significantly reduced PM2.5-induced intracellular and mitochondrial ROS levels, restored mitochondrial morphology and membrane potential, and inhibited the expression of inflammatory genes. PMC10353144
L6 myotubes 50 μM 30 min heating followed by 7 h incubation BGP-15 increased HSF-1 at 30 min and HSP72 at 60 min but had no effect on HSP90 levels PMC2234214
Dorsal root ganglia neurons 10 μM BGP-15 improved mitochondrial function, restored mitochondrial membrane potential, reduced reactive oxygen species (ROS) levels, and partially restored mitochondrial morphology. PMC5441694
Mouse oocytes 10 μM 14 hours BGP-15 protected mouse oocytes against spindle and chromosomal defects induced by oxidative stress and aging during in vitro maturation. PMC7891816

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Obese or reproductively aged female mouse model Intraperitoneal injection 100 mg/kg Once daily for 4 days Restored oocyte mitochondrial function and improved offspring telomere length PMC11909127
C57/BL6 mice PM2.5-induced acute lung injury model Intraperitoneal injection 20 mg/kg Once daily for two consecutive days Pretreatment with BGP-15 significantly attenuated PM2.5-induced lung inflammation and airway hyperresponsiveness, restored lung compliance, and reduced the expression of mitochondrial fission proteins. PMC10353144
Mice Reproductively aged mice Drinking water and intraperitoneal injection 100 mg/kg 2 weeks in drinking water plus 4 days injection BGP-15 treatment reduced ovarian fibrosis, increased the number of ovulated oocytes, and improved oocyte developmental competence. PMC9205599
Ob/ob mice Genetic obesity model Oral gavage 15 mg/kg/day Once daily for 15 days BGP-15 treatment significantly increased HSP72 protein expression in skeletal muscle, reduced JNK phosphorylation, improved fasting glucose and insulin levels, and enhanced insulin sensitivity PMC2234214
Mice Ikbkap/Elp1 conditional knockout mice Intraperitoneal injection 100 mg/kg Once daily from E12.5 to E16.5 BGP-15 significantly reduced the death of Ikbkap?/? sensory neurons, restored cardiac innervation, and decreased pJNK levels. PMC5441694
Balb/c mice Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction model Intraperitoneal injection 15 mg/kg/day Three times a week for 14 days BGP-15 ameliorated oxidative stress, increased enteric neuronal survival and alleviated oxaliplatin-induced intestinal dysfunction. PMC5786462
Rats Type 2 diabetes model (Goto-Kakizaki rats) Oral 5, 10, 20, and 30 mg/kg Once daily for five days To evaluate the effect of BGP-15 on insulin sensitivity, results showed that BGP-15 increased mitochondrial number and insulin sensitivity. PMC4030108
Mice Reproductively aged mouse model In vitro culture 10 μM 14 hours BGP-15 significantly elevated MMP levels and maturation rates in oocytes from 18-month-old mice, and reduced chromosomal misalignments. PMC7891816

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01069965 Diabetes Mellitus Phase 2 Terminated(Funding support wit... More >>hdrawn.) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.28mL

14.23mL

2.85mL

1.42mL

28.47mL

5.69mL

2.85mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories